Global Screening Array (GSA) for Population Genomics

Discover the power of our GSA service for genetic research, disease studies, pharmacogenetics and more.  Our Illumina Infinium Global Screening Array (GSA v3) offers a flexible and affordable solution for population genetics, with expertly curated global content also available to customise your application.
 

Discover the advantages:

  • Available booster content: Multi-disease, Psychiatric, Direct to Consumer, Confluence oncology (breast cancer), Cytogenetics

  • Multiethnic genome wide content

  • Scalable, high throughput processing

  • Wide range of clinical research applications

  • Optimised global content

  • Cost effective

AGRF has provided genotyping services with Illumina array technology since 2008. The laboratory has genotyped over 180,000 samples across more than 4,000 projects. Accredited as a Medical Testing laboratory according to the ISO15189 standard by the National Association of Testing Authorities (NATA), the AGRF Illumina SNP array service ensures the highest quality data.

Previous project work has involved studies in human genetic disease, oncology (ovarian, breast, melanoma and brain cancers), and population wide studies of Schizophrenia, Alzheimer’s, childhood allergies, and Diabetes. AGRF’s projects come from a diverse range of fields, including the research community, cytogenetics, agriculture, and personal genomics, and encompass a wide range of sample types.